Mutant proteins as cancer-specific biomarkers - Test2 - elhamkhani - TriplyDB

Mutant proteins as cancer-specific biomarkers

Mutant proteins as cancer-specific biomarkers

http://www.wikidata.org/entity/Q24625180

about

Recent progress in pancreatic cancer The Size of the Human Proteome: The Width and Depth Surgical and molecular pathology of pancreatic neoplasms Yessotoxin, a Promising Therapeutic Tool Applications of targeted proteomics in systems biology and translational medicine Early diagnosis of pancreatic cancer: challenges and new developments Impact of allele-specific peptides in proteome quantification Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients TSNAD: an integrated software for cancer somatic mutation and tumour-specific neoantigen detection Serum Levels of Glycoproteins are Elevated in Patients with Ovarian Cancer Proteogenomic convergence for understanding cancer pathways and networks.Exosomes in bodily fluids are a highly stable resource of disease biomarkers Identification of trunk mutations in gastric carcinoma: a case study Ras in cancer and developmental diseases Genetic evolution of pancreatic cancer: lessons learnt from the pancreatic cancer genome sequencing project.Quantitative analysis of single amino acid variant peptides associated with pancreatic cancer in serum by an isobaric labeling quantitative method.Identification of a novel proteoform of prostate specific antigen (SNP-L132I) in clinical samples by multiple reaction monitoring Emerging tactical strategies for fighting the war on cancer based on the genetic landscape Serial analysis of 38 proteins during the progression of human breast tumor in mice using an antibody colocalization microarray.The use of protein-based biomarkers for the diagnosis of cystic tumors of the pancreas Evaluating kinase ATP uptake and tyrosine phosphorylation using multiplexed quantification of chemically labeled and post-translationally modified peptides.Proteomics in cancer biomarkers discovery: challenges and applications.Using quantitative proteomic analysis to understand genotype specific intrinsic drug resistance in melanoma.Different toxic effects of YTX in tumor K-562 and lymphoblastoid cell lines.Absolute Quantification of Endogenous Ras Isoform Abundance A proteomic approach to obesity and type 2 diabetes.Evaluation of direct infusion-multiple reaction monitoring mass spectrometry for quantification of heat shock proteins.Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics.Advances in Proteomic Technologies and Its Contribution to the Field of Cancer Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum.Detection of a rare BCR-ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS)The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification.Protein isoform-specific validation defines multiple chloride intracellular channel and tropomyosin isoforms as serological biomarkers of ovarian cancer.Proteogenomics: Integrating Next-Generation Sequencing and Mass Spectrometry to Characterize Human Proteomic Variation Mass spectrometric protein maps for biomarker discovery and clinical research.A proteogenomic approach for protein-level evidence of genomic variants in cancer cells.Long-gradient separations coupled with selected reaction monitoring for highly sensitive, large scale targeted protein quantification in a single analysis.Comparison of protein immunoprecipitation-multiple reaction monitoring with ELISA for assay of biomarker candidates in plasma.Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach.

P2860

Q24626346-13FAEF85-BAAA-482B-8FAD-5A02FEEC8758 Q26746173-28C0308B-B5BB-4D8D-A686-3523DB6DA8DE Q26748615-59199A6A-2BEB-4D4E-BE55-C605C73D5CC4 Q26772932-6D0ACC20-4BBA-4A56-AB65-DAA97DD820C4 Q26852271-E6E92119-C6EB-4C96-8764-5405D56A27F2 Q27014027-8C7DAAE0-5CE7-4870-B5F6-03CA06018FFB Q27016149-4DB8210F-4DB8-4738-A03D-43EA4C697E20 Q33555287-60B0A672-1AEC-4F3F-9BE9-0FE65D93D626 Q33630241-F076205C-8DBA-43AE-9B06-5B99667EB120 Q33774597-146F884D-81AD-42E2-B735-C174985BA256 Q33792433-F7195D91-E719-4AC6-A1A1-93B69D0B31E2 Q33885679-403FA281-0C0C-4A38-8821-A40EEC179C75 Q33921459-EAA7872C-15CB-4674-976C-25707BE50273 Q34202697-03AEAAD6-3632-444F-9783-E98290A4E1CA Q34630956-D31713F6-3F26-468A-83BC-647ACB2D05EC Q34669441-8DCEB78F-908D-45BD-A44C-AD681C7FF639 Q34810177-28561443-B63E-4743-BB61-B77F94306A1E Q35008971-459CDF44-5E70-4202-821E-50B98CF35F0B Q35325472-B9D88F23-0144-4D25-9BF8-4DB50069B574 Q35450240-1A951396-7AF0-4E86-847B-8F48D791C342 Q35579916-E281C9D0-A5C3-4711-966E-F85714C859A6 Q35592114-D97A05D1-C3D4-44F5-B9EA-EBB095A968D6 Q35640196-25844B73-F2A3-435D-87D3-DDDA9650346C Q35749454-B85111E3-463E-48EA-8D6B-0547EC83099A Q35839061-80637C4C-B75F-4AA6-A680-E03C5C4116F6 Q35879468-137592B4-57A8-419D-A02A-06CC0EF0D97B Q35903689-851477D1-58E0-4BE0-A4C9-DC745ABE54DC Q36031629-26C21F5E-5918-46E5-BC58-2C5E74017E87 Q36112651-3C618659-9FFD-499B-808D-C5CBE49D778C Q36280125-7AD69B93-7B27-49F7-B001-2D36594119BE Q36342992-E5A4D8AF-7321-40E2-A601-AFF0B00DB6E3 Q36771005-9CDC487C-70B6-4E46-AEF2-C088269439E8 Q37187957-BCF56CE1-3DFA-4658-8279-7B58E50492A1 Q37190570-3D04A72F-3487-49CA-897E-16A032EF31CC Q37324690-8EC40464-CF1D-4147-870D-6C05D44F0D15 Q37335640-C5FC3E43-3E72-43FD-B4FD-E5A569B260D0 Q37341145-6E764C30-96E5-4CCB-B118-D4B7155AA1F9 Q37394942-34CB651B-D10B-4A16-B33E-16273CBC9FAE Q37618631-A4067873-FC71-4638-8DF0-7E5CA21269F4 Q37623655-2658F684-5037-4BBC-B081-70DC634EE176

P2860

Mutant proteins as cancer-specific biomarkers

http://www.wikidata.org/entity/Q24625180

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Mutant proteins as cancer-specific biomarkers

@ast

Mutant proteins as cancer-specific biomarkers

@en

Mutant proteins as cancer-specific biomarkers

@nl

type

label

Mutant proteins as cancer-specific biomarkers

@ast

Mutant proteins as cancer-specific biomarkers

@en

Mutant proteins as cancer-specific biomarkers

@nl

prefLabel

Mutant proteins as cancer-specific biomarkers

@ast

Mutant proteins as cancer-specific biomarkers

@en

Mutant proteins as cancer-specific biomarkers

@nl

P1433

Q24625180-58573E18-CF28-45B0-AE3A-5A57046D7FE4

P1476

Q24625180-A2F610BD-C645-4822-ABAF-55431527C5C8

P2093

Q24625180-18799999-FC3F-4ECF-8942-039886A20AAF

Q24625180-7623D785-016C-4972-8954-2C9F841E9ACD

Q24625180-8ACF672D-0E4D-4BBE-BE44-F2F5575FCD4B

Q24625180-8D9CE62E-13ED-480A-A16A-7509F7544DCA

Q24625180-9031B297-4A86-4498-A83A-8A22E33032D8

Q24625180-9575B9D5-DB0E-45A3-AA26-B68C999A9E89

Q24625180-CD64B8A9-1783-4943-A8AA-F7627AF9DA26

Q24625180-EC3E1009-8ADA-44EB-90F9-B66BA98EA1C1

Q24625180-F8DA0F80-DD6F-4F94-A25E-DC74434CCED1

P2860

Q24625180-0733C3E0-3867-4A81-99D9-684FAFF95E72

Q24625180-09EACFB1-683D-4BFC-B7EF-9199DA33D82F

Q24625180-15E96983-F3C6-498E-AA7C-0F7ACDE278E4

Q24625180-186E5449-DE43-4724-9A27-4235ED7F631E

Q24625180-1BC42C22-A857-4D6D-903C-E4406DA03C1A

Q24625180-1C791E78-FA3E-433E-9795-130A9B544999

Q24625180-2396C53E-A870-4A06-A742-DE510CBAAEEE

Q24625180-2C43A252-ECCE-4856-960D-FF5F418D7FBF

Q24625180-423CDB53-D9B9-47A6-90D8-8382D4525462

Q24625180-4AF5C235-686E-4E7C-B86C-A73C7CF3233C

P304

Q24625180-595A89F5-386F-4AD3-ADC1-DF2358968D0F

P31

Q24625180-87CA7275-FF39-47F4-A5D0-8E23460BA087

P3181

Q24625180-36FEE4D6-09AF-438D-B92A-6B66A7DDB32C

P356

Q24625180-1F654272-41C9-4402-AFB1-948CEE053442

P407

Q24625180-5B1B0196-EF99-424C-B62E-59916E68042F

P433

Q24625180-CA50F2F9-A596-4AB6-A844-6FD06C9FC52B

P478

Q24625180-DBF18C5F-8852-4C9E-8FD5-8AC6A659D506

P50

Q24625180-0CA78AF7-DD05-4A42-BBCF-08CCDB9408F8

Q24625180-221D128D-812C-42BF-ABBE-4A1F167C7843

Q24625180-2594DC43-15E3-4A38-BBFD-0B5FD0F8EAE3

Q24625180-59202EB2-ED17-41B1-A597-4D608A1025DA

P577

Q24625180-BD195E37-8857-4962-9A59-D22A9C861D22

P5875

Q24625180-AEA98B77-7207-41E4-B93D-AAD34B80690E

P698

Q24625180-7D159F6F-3A4B-4C4A-AED5-3DA9EE3912B9

P921

Q24625180-61B5C7D4-D69A-4EB4-9DE3-1CA3EBE601D6

P932

Q24625180-ECBF0731-5933-459E-A712-A54C839B6257

P3181

P356

PNAS.1019203108

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Mutant proteins as cancer-specific biomarkers

@en

P2093

Anirban Maitra

http://www.w3.org/2001/XMLSchema#string

Hanno Matthaei

http://www.w3.org/2001/XMLSchema#string

Hee Jung Hwang

http://www.w3.org/2001/XMLSchema#string

James R Eshleman

http://www.w3.org/2001/XMLSchema#string

Jian Wu

http://www.w3.org/2001/XMLSchema#string

Levy Kopelovich

http://www.w3.org/2001/XMLSchema#string

Nick Papadopoulos

http://www.w3.org/2001/XMLSchema#string

Qing Wang

http://www.w3.org/2001/XMLSchema#string

Raghothama Chaerkady

http://www.w3.org/2001/XMLSchema#string

P2860

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

An integrated genomic analysis of human glioblastoma multiforme

Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS

The genomic landscapes of human breast and colorectal cancers

Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics

The cancer genome

Skyline: an open source document editor for creating and analyzing targeted proteomics experiments

Characterization of transthyretin variants in familial transthyretin amyloidosis by mass spectrometric peptide mapping and DNA sequence analysis.

Detection and validation of non-synonymous coding SNPs from orthogonal analysis of shotgun proteomics data.

Contributions of advanced proteomics technologies to cancer diagnosis.

P304

2444-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

982417

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.1019203108

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Ralph H. Hruban

Kenneth W Kinzler

Akhilesh Pandey

Bert Vogelstein

P577

2011-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49768068

http://www.w3.org/2001/XMLSchema#string

P698

21248225

http://www.w3.org/2001/XMLSchema#string

P921

P932

3038743

http://www.w3.org/2001/XMLSchema#string